ID: ALA4800039

Max Phase: Preclinical

Molecular Formula: C29H40BrN9O7

Molecular Weight: 706.60

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2c[nH]c3c(Br)cccc23)C(=O)N1C

Standard InChI:  InChI=1S/C29H40BrN9O7/c1-14(2)24-27(45)37-18(8-5-9-33-29(31)32)25(43)35-13-21(40)36-19(11-22(41)42)26(44)38-20(28(46)39(24)3)10-15-12-34-23-16(15)6-4-7-17(23)30/h4,6-7,12,14,18-20,24,34H,5,8-11,13H2,1-3H3,(H,35,43)(H,36,40)(H,37,45)(H,38,44)(H,41,42)(H4,31,32,33)/t18-,19-,20+,24-/m0/s1

Standard InChI Key:  RTHTZKFWJRGDKZ-KTIHBUSBSA-N

Associated Targets(Human)

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-5/beta-1 686 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 706.60Molecular Weight (Monoisotopic): 705.2234AlogP: -0.72#Rotatable Bonds: 9
Polar Surface Area: 251.70Molecular Species: ZWITTERIONHBA: 7HBD: 9
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.02CX Basic pKa: 11.90CX LogP: -2.81CX LogD: -2.81
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.09Np Likeness Score: 0.95

References

1. Kemker I,Schröder DC,Feiner RC,Müller KM,Marion A,Sewald N.  (2021)  Tuning the Biological Activity of RGD Peptides with Halotryptophans†.,  64  (1.0): [PMID:33356253] [10.1021/acs.jmedchem.0c01536]

Source